Table 1.
Baseline characteristics
| Characteristic | All (N = 72) | C-MVR (N = 56) | H-TMVR (N = 16) | P |
|---|---|---|---|---|
| Age, mean (SD) | 71.6 (10.9) | 70.9 (10.7) | 73.9 (11.3) | .340 |
| Female, n (%) | 50 (69.44%) | 37 (66.07%) | 13 (81.25%) | .245 |
| HTN, n (%) | 55 (76.39%) | 41 (73.21%) | 14 (87.50%) | .235 |
| Pulmonary HTN, n (%) | 47 (65.28%) | 37 (66.07%) | 10 (62.50%) | .791 |
| DM, n (%) | 19 (26.39%) | 14 (25.00%) | 5 (31.25%) | .617 |
| HLD, n (%) | 52 (72.22%) | 40 (71.43%) | 12 (75.00%) | .779 |
| CAD, n (%) | 43 (59.72%) | 31 (55.36%) | 12 (75.00%) | .158 |
| CHF, n (%) | 27 (37.50%) | 22 (39.29%) | 5 (31.25%) | .558 |
| CKD, n (%) | 16 (22.22%) | 13 (23.21%) | 3 (18.75%) | .705 |
| Chronic lung disease, n (%) | 8 (11.11%) | 6 (10.71%) | 2 (12.50%) | .841 |
| Rheumatic disease, n (%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | - |
| Endocarditis, n (%) | 2 (2.78%) | 2 (3.57%) | 0 (0.00%) | .443 |
| Mediastinal radiation, n (%) | 12 (16.67%) | 9 (16.07%) | 3 (18.75%) | .799 |
| Atrial fibrillation, n (%) | 35 (48.61%) | 27 (48.21%) | 8 (50.00%) | .899 |
| MI, n (%) | 9 (12.50%) | 6 (10.71%) | 3 (18.75%) | .391 |
| Previous intervention, n (%) | 26 (36.11%) | 21 (37.50%) | 5 (31.25%) | .646 |
| Median sternotomy | 19 (73.08%) | 14 (66.67%) | 5 (100.00%) | .131 |
| TAVR | 4 (15.38%) | 4 (19.05%) | 0 (0.00%) | .289 |
| MitraClip | 3 (11.54%) | 3 (14.29%) | 0 (0.00%) | .369 |
| NYHA 3+, n (%) | 51 (70.83%) | 39 (69.64%) | 12 (75.00%) | .678 |
| MAC Class, n (%) | .001 | |||
| Circumferential | 19 (26.39%) | 10 (17.86%) | 9 (56.25%) | |
| Horseshoe | 12 (16.67%) | 8 (14.29%) | 4 (25.00%) | |
| Partial | 41 (56.94%) | 38 (67.86%) | 3 (18.75%) | |
| MV disease, n (%) | .002 | |||
| Mixed | 21 (29.58%) | 14 (25.45%) | 7 (43.75%) | |
| Pure regurgitation | 31 (43.66%) | 30 (54.55%) | 1 (6.25%) | |
| Pure stenosis | 19 (26.76%) | 11 (20.00%) | 8 (50.00%) | |
| EF, mean (Standard deviation) | 62.2% (7.5%) | 61.2% (6.9%) | 65.7% (8.9%) | .035 |
| STS score, median (Interquartile range) | 4.1% (2.4%-6.4%) | 4.1% (2.0%-6.0%) | 4.7% (3.3%-8.2%) | .332 |
C-MVR, Conventional mitral valve replacement; H-TMVR, hybrid transcatheter mitral valve replacement; HTN, hypertension; DM, diabetes mellitus; HLD, hyperlipidemia; CAD, coronary artery disease; CHF, congestive heart failure; CKD, chronic kidney disease; MI, myocardial infarction; TAVR, transcatheter aortic valve replacement; NYHA, New York Heart Association; MAC, mitral annular calcification; MV, mitral valve; EF, ejection fraction; STS, Society of Thoracic Surgeons.